Global K Cells Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by K Cells Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global K Cells Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Mogamulizumab
  • 1.4.3 Lorvotuzumab Mertansine
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global K Cells Market Share by Application: 2020 VS 2026
  • 1.5.2 Cancer
  • 1.5.3 Cardiovascular Diseases
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 K Cells Market Perspective (2015-2026)
• 2.2 K Cells Growth Trends by Regions
  • 2.2.1 K Cells Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 K Cells Historic Market Share by Regions (2015-2020)
  • 2.2.3 K Cells Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 K Cells Market Growth Strategy
  • 2.3.6 Primary Interviews with Key K Cells Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top K Cells Players by Market Size
  • 3.1.1 Global Top K Cells Players by Revenue (2015-2020)
  • 3.1.2 Global K Cells Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global K Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global K Cells Market Concentration Ratio
  • 3.2.1 Global K Cells Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by K Cells Revenue in 2019
• 3.3 K Cells Key Players Head office and Area Served
• 3.4 Key Players K Cells Product Solution and Service
• 3.5 Date of Enter into K Cells Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global K Cells Historic Market Size by Type (2015-2020)
• 4.2 Global K Cells Forecasted Market Size by Type (2021-2026)

5 K Cells Breakdown Data by Application (2015-2026)

• 5.1 Global K Cells Market Size by Application (2015-2020)
• 5.2 Global K Cells Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America K Cells Market Size (2015-2020)
• 6.2 K Cells Key Players in North America (2019-2020)
• 6.3 North America K Cells Market Size by Type (2015-2020)
• 6.4 North America K Cells Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe K Cells Market Size (2015-2020)
• 7.2 K Cells Key Players in Europe (2019-2020)
• 7.3 Europe K Cells Market Size by Type (2015-2020)
• 7.4 Europe K Cells Market Size by Application (2015-2020)

8 China

• 8.1 China K Cells Market Size (2015-2020)
• 8.2 K Cells Key Players in China (2019-2020)
• 8.3 China K Cells Market Size by Type (2015-2020)
• 8.4 China K Cells Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan K Cells Market Size (2015-2020)
• 9.2 K Cells Key Players in Japan (2019-2020)
• 9.3 Japan K Cells Market Size by Type (2015-2020)
• 9.4 Japan K Cells Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia K Cells Market Size (2015-2020)
• 10.2 K Cells Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia K Cells Market Size by Type (2015-2020)
• 10.4 Southeast Asia K Cells Market Size by Application (2015-2020)

11 India

• 11.1 India K Cells Market Size (2015-2020)
• 11.2 K Cells Key Players in India (2019-2020)
• 11.3 India K Cells Market Size by Type (2015-2020)
• 11.4 India K Cells Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America K Cells Market Size (2015-2020)
• 12.2 K Cells Key Players in Central & South America (2019-2020)
• 12.3 Central & South America K Cells Market Size by Type (2015-2020)
• 12.4 Central & South America K Cells Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Takeda Pharmaceutical (Japan)
  • 13.1.1 Takeda Pharmaceutical (Japan) Company Details
  • 13.1.2 Takeda Pharmaceutical (Japan) Business Overview and Its Total Revenue
  • 13.1.3 Takeda Pharmaceutical (Japan) K Cells Introduction
  • 13.1.4 Takeda Pharmaceutical (Japan) Revenue in K Cells Business (2015-2020))
  • 13.1.5 Takeda Pharmaceutical (Japan) Recent Development
• 13.2 Sorrento Therapeutics Inc. (USA)
  • 13.2.1 Sorrento Therapeutics Inc. (USA) Company Details
  • 13.2.2 Sorrento Therapeutics Inc. (USA) Business Overview and Its Total Revenue
  • 13.2.3 Sorrento Therapeutics Inc. (USA) K Cells Introduction
  • 13.2.4 Sorrento Therapeutics Inc. (USA) Revenue in K Cells Business (2015-2020)
  • 13.2.5 Sorrento Therapeutics Inc. (USA) Recent Development
• 13.3 NantKwest Inc. (USA)
  • 13.3.1 NantKwest Inc. (USA) Company Details
  • 13.3.2 NantKwest Inc. (USA) Business Overview and Its Total Revenue
  • 13.3.3 NantKwest Inc. (USA) K Cells Introduction
  • 13.3.4 NantKwest Inc. (USA) Revenue in K Cells Business (2015-2020)
  • 13.3.5 NantKwest Inc. (USA) Recent Development
• 13.4 Bristol-Myers Squibb (USA)
  • 13.4.1 Bristol-Myers Squibb (USA) Company Details
  • 13.4.2 Bristol-Myers Squibb (USA) Business Overview and Its Total Revenue
  • 13.4.3 Bristol-Myers Squibb (USA) K Cells Introduction
  • 13.4.4 Bristol-Myers Squibb (USA) Revenue in K Cells Business (2015-2020)
  • 13.4.5 Bristol-Myers Squibb (USA) Recent Development
• 13.5 NKT Therapeutics (USA)
  • 13.5.1 NKT Therapeutics (USA) Company Details
  • 13.5.2 NKT Therapeutics (USA) Business Overview and Its Total Revenue
  • 13.5.3 NKT Therapeutics (USA) K Cells Introduction
  • 13.5.4 NKT Therapeutics (USA) Revenue in K Cells Business (2015-2020)
  • 13.5.5 NKT Therapeutics (USA) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer